Nutritional Supplements on Blood Pressure 2008 - Full Text View

Sponsored by:	Logan College of Chiropractic
Information provided by:	Logan College of Chiropractic
ClinicalTrials.gov Identifier:	NCT00609570

Purpose

Three different supplements will be used in the study (fruits and vegetable powders, whey protein and calcium) for patients with hypertension. The null hypothesis was that the supplements had no effects on participants' blood pressure.

Condition	Intervention	Phase
Hypertension	Dietary Supplement: NanoGreens Dietary Supplement: Whey protein Dietary Supplement: Calcium pills	Phase I

MedlinePlus related topics: Calcium Dietary Supplements High Blood Pressure

Drug Information available for: Calcium gluconate

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind (Investigator), Active Control, Factorial Assignment, Efficacy Study
Official Title:	Effects of Nutritional Supplements on Blood Pressure and Heart Rate Variability

Further study details as provided by Logan College of Chiropractic:

Primary Outcome Measures:

Blood pressure and HRV [ Time Frame: every two weeks for three months ] [ Designated as safety issue: No ]

Estimated Enrollment:	60
Study Start Date:	October 2008
Estimated Study Completion Date:	July 2009
Estimated Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Fruit and vegetables: Experimental Fruits and vegetables	Dietary Supplement: NanoGreens fruits and vegetables
Whey protein: Active Comparator Whey protein	Dietary Supplement: Whey protein Whey
Ca: Active Comparator Calcium pills	Dietary Supplement: Calcium pills CA

Detailed Description:

Hypertensive participants will be randomly assigned into three groups. The first group of participants will take the fruits and vegetable powders mixed with water. The second group takes whey protein and the third group takes calcium pills. Blood pressure and heart rate variability will be measured every two weeks for three months.

Eligibility

Ages Eligible for Study:	20 Years to 70 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Age 20-70
Hypertensive male and female subjects.

Exclusion Criteria:

Severe cardiovascular and renal conditions.
Pregnancies and taking medications.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00609570

Contacts

Contact: John Zhang, MD PhD

636 230 1920

john.zhang@logan.edu

Locations

United States, Missouri
Logan University	Not yet recruiting
Chesterfield, Missouri, United States, 63017
Contact: John Zhang, MD, PhD 636-230-1920 john.zhang@logan.edu
Logan University, College of Chiropractic	Recruiting
Chesterfield, Missouri, United States, 63006
Contact: John Zhang, MD, Phd 636-230-1920 john.zhang@logan.edu

Sponsors and Collaborators

Logan College of Chiropractic

Investigators

Study Chair:

John Zhang, MD, PhD

Logan University

More Information

Responsible Party:	Logan University ( John Zhang )
Study ID Numbers:	RD0920070111
Study First Received:	January 25, 2008
Last Updated:	October 27, 2008
ClinicalTrials.gov Identifier:	NCT00609570
Health Authority:	United States: Institutional Review Board

Keywords provided by Logan College of Chiropractic:

hypertension
supplement
HRV

Study placed in the following topic categories:

Calcium, Dietary
Vascular Diseases
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009